Faron Pharmaceuticals Ltd
8 clinical trials · Sponsor
◉ Watch Faron Pharmaceuticals Ltd
| Record | Firm | Date |
|---|---|---|
| Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes (NCT07672769) | Faron Pharmaceuticals Ltd | 2026-10-01 |
| A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (NCT05428969) | Faron Pharmaceuticals Ltd | 2022-06-02 |
| A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma (NCT05104905) | Faron Pharmaceuticals Ltd | 2021-10-07 |
| Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19 (NCT04860518) | Faron Pharmaceuticals Ltd | 2021-08-23 |
| A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) (NCT03733990) | Faron Pharmaceuticals Ltd | 2018-12-03 |
Track Faron Pharmaceuticals Ltd automatically
Every clearance here is in the API, with alerts when new ones post.